Itolizumab Injection Current Affairs - 2020

GoI decides against including Itolizumab in treating COVID-19

The National Task Force on COVID-19 recently decided against using Itolizumab in clinical management protocols. The Drugs Controller General of India (DCGI) had earlier approved for “restricted emergency use” of the drug. Highlights Itolizumab is used to treat psoriasis. It was recently approved for the treatment of cytokine release syndrome in ‘moderate’ to ‘severe’ acute Read More…

Japan approves Dexamethasone as COVID-19 Treatment

The Japanese Government recently approved Dexamethasone as a second treatment of COVID-19. The approval came in after Britain showed that the drug reduced death rates in COVID-19 patients. Highlights Dexamethasone has been approved for treatment along with Remdesivir. A clinical trial of UK proved that Dexamethasone as the first drug saved lives of COVID-19. India Read More…

‘Itolizumab’ Injection gets DCGI Approval for Treatment of Moderate to Serve ARDS Patients

The Drug Controller General of India (DCGI) has given its approval to ‘Itolizumab’ injection for the treatment of COVID-19 patients with restricted emergency use only in case of moderate to severe Acute Respiratory Distress Syndrome (ARDS) patients. DCGI has made it clear that written informed consent of the patient will be required by the authorities Read More…